These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 36387244)

  • 1. Establishment of a prognostic nomogram for patients with locoregionally advanced nasopharyngeal carcinoma incorporating clinical characteristics and dynamic changes in hematological and inflammatory markers.
    Liu Q; Ma L; Ma H; Yang L; Xu Z
    Front Oncol; 2022; 12():1032213. PubMed ID: 36387244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiomics-based nomogram guides adaptive de-intensification in locoregionally advanced nasopharyngeal carcinoma following induction chemotherapy.
    Wang SX; Yang Y; Xie H; Yang X; Liu ZQ; Li HJ; Huang WJ; Luo WJ; Lei YM; Sun Y; Ma J; Chen YF; Liu LZ; Mao YP
    Eur Radiol; 2024 Oct; 34(10):6831-6842. PubMed ID: 38514481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishment of a Prognostic Nomogram for Patients With Locoregionally Advanced Nasopharyngeal Carcinoma Incorporating TNM Stage, Post-Induction Chemotherapy Tumor Volume and Epstein-Barr Virus DNA Load.
    Jiang YT; Chen KH; Yang J; Liang ZG; Qu S; Li L; Zhu XD
    Front Oncol; 2021; 11():683475. PubMed ID: 34222003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A dynamic nomogram combining tumor stage and magnetic resonance imaging features to predict the response to induction chemotherapy in locally advanced nasopharyngeal carcinoma.
    Jiang Y; Liang Z; Chen K; Li Y; Yang J; Qu S; Li L; Zhu X
    Eur Radiol; 2023 Mar; 33(3):2171-2184. PubMed ID: 36355201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delta magnetic resonance imaging radiomics features‑based nomogram predicts long‑term efficacy after induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma.
    Pan GS; Sun XM; Kong FF; Wang JZ; He XY; Lu XG; Hu CS; Dong SX; Ying HM
    Oral Oncol; 2024 Oct; 157():106987. PubMed ID: 39133972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishing and applying nomograms based on the 8th edition of the UICC/AJCC staging system to select patients with nasopharyngeal carcinoma who benefit from induction chemotherapy plus concurrent chemoradiotherapy.
    Xu C; Chen YP; Liu X; Li WF; Chen L; Mao YP; Zhang Y; Guo R; Zhou GQ; Tang LL; Lin AH; Sun Y; Ma J
    Oral Oncol; 2017 Jun; 69():99-107. PubMed ID: 28559028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multidimensional nomogram combining overall stage, dose volume histogram parameters and radiomics to predict progression-free survival in patients with locoregionally advanced nasopharyngeal carcinoma.
    Yang K; Tian J; Zhang B; Li M; Xie W; Zou Y; Tan Q; Liu L; Zhu J; Shou A; Li G
    Oral Oncol; 2019 Nov; 98():85-91. PubMed ID: 31569054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic nomogram for patients with Nasopharyngeal Carcinoma incorporating hematological biomarkers and clinical characteristics.
    Li J; Chen S; Peng S; Liu Y; Xing S; He X; Chen H
    Int J Biol Sci; 2018; 14(5):549-556. PubMed ID: 29805306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nomogram Based on Lactate Dehydrogenase-to-Albumin Ratio (LAR) and Platelet-to-Lymphocyte Ratio (PLR) for Predicting Survival in Nasopharyngeal Carcinoma.
    Peng RR; Liang ZG; Chen KH; Li L; Qu S; Zhu XD
    J Inflamm Res; 2021; 14():4019-4033. PubMed ID: 34447260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A nomogram based on circulating CD8
    Yan C; Yang G; Zhang C; Chen K; Sun Y; Liang Z; Lai L; Li L; Qu S; Zhu XD
    Radiat Oncol; 2024 Aug; 19(1):108. PubMed ID: 39138513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Relationship between preoperative inflammatory indexes and prognosis of patients with rectal cancer and establishment of prognostic nomogram prediction model].
    Zhang L; Shi FY; Qin Q; Liu GX; Zhang HW; Yan J; Tan M; Wang LZ; Xue D; Hu CH; Zhang Z; She JJ
    Zhonghua Zhong Liu Za Zhi; 2022 May; 44(5):402-409. PubMed ID: 35615796
    [No Abstract]   [Full Text] [Related]  

  • 12. MRI-based radiomics to compare the survival benefit of induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy plus adjuvant chemotherapy in locoregionally advanced nasopharyngeal carcinoma: A multicenter study.
    Shen H; Yin J; Niu R; Lian Y; Huang Y; Tu C; Liu D; Wang X; Lan X; Yuan X; Zhang J
    Radiother Oncol; 2022 Jun; 171():107-113. PubMed ID: 35461950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and Validation of Prognostic Nomograms Based on Gross Tumor Volume and Cervical Nodal Volume for Nasopharyngeal Carcinoma Patients With Concurrent Chemoradiotherapy.
    Zhang CD; Li M; Hong YJ; Cai ZM; Huang KC; Lin ZX; Yang ZN
    Front Oncol; 2021; 11():682271. PubMed ID: 34262866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MRI-identified multidimensional nodal features predict survival and concurrent chemotherapy benefit for stage II nasopharyngeal carcinoma.
    Liu Y; Zhang J; Wang J; Wu R; Huang X; Wang K; Qu Y; Chen X; Li Y; Zhang Y; Yi J
    Radiol Oncol; 2022 Dec; 56(4):479-487. PubMed ID: 36503717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Residual Volume of Lymph Nodes During Chemoradiotherapy Based Nomogram to Predict Survival of Nasopharyngeal Carcinoma Patient Receiving Induction Chemotherapy.
    Li Y; Zang J; Liu J; Luo S; Wang J; Hou B; Zhao L; Shi M
    Front Oncol; 2021; 11():739103. PubMed ID: 34552881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. External validity of a prognostic nomogram for locoregionally advanced nasopharyngeal carcinoma based on the 8th edition of the AJCC/UICC staging system: a retrospective cohort study.
    OuYang PY; You KY; Zhang LN; Xiao Y; Zhang XM; Xie FY
    Cancer Commun (Lond); 2018 Sep; 38(1):55. PubMed ID: 30176932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nomogram Based on Inflammatory Biomarkers and Nutritional Indicators for Predicting Overall Survival in Locoregionally Advanced Nasopharyngeal Carcinoma.
    Zhao R; Liang Z; Chen K; Zhu X
    J Inflamm Res; 2022; 15():2971-2981. PubMed ID: 35602661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nomogram Based on Hemoglobin, Albumin, Lymphocyte and Platelet Score to Predict Overall Survival in Patients with T3-4N0-1 Nasopharyngeal Carcinoma.
    Zhao R; Liang Z; Chen K; Zhu X
    J Inflamm Res; 2023; 16():1995-2006. PubMed ID: 37193071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of magnetic resonance imaging-derived skeletal muscle index in locoregionally advanced nasopharyngeal carcinoma.
    Jiang J; Cai Z; Zheng R; Yuan Y; Lv X; Qiu W
    Eur Arch Otorhinolaryngol; 2024 Jul; 281(7):3707-3715. PubMed ID: 38671169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nomograms based on the lymphocyte-albumin-neutrophil ratio (LANR) for predicting the prognosis of nasopharyngeal carcinoma patients after definitive radiotherapy.
    Zhang S; Chen Z; Ling J; Feng Y; Xie Y; Liu X; Hu C; Hou T
    Sci Rep; 2024 Mar; 14(1):5388. PubMed ID: 38443675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.